Tag: Biofourmis
Biofourmis Receives FDA Breakthrough Device Designation for Novel Digital Therapeutic for Heart Failure
Boston-based virtual care provider Biofourmis dreams of a future where heart failure patients will stay home where they will be remotely monitored via a wearable sensor and an app. The […]
Biofourmis Raises $100 Million In Series C Funding To Accelerate Global Expansion
Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised $100 million Series C financing round led by SoftBank Vision Fund 2, with […]
Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain
Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment […]
Biofourmis’ AI-Powered Tech Being Used in Remote Monitoring of COVID-19 Patients in Hong Kong
Biofourmis, a developer of digital therapeutics that powers personalized predictive care, announced that its technology is being leveraged in a remote monitoring and disease surveillance program in Hong Kong involving […]
Biofourmis Collaborates with ImagineMIC to Improve Remote Patient Monitoring for Chronic Disease Patients
Biofourmis, a fast-growing global health IT start-up founded in Singapore, and ImagineMIC, a New York-based medical device company formed a partnership to drive improved outcomes and lower healthcare costs for […]
Biofourmis Buys Biovotion to Deliver Precise Interventions for Patients with Complex Chronic Conditions
US-based digital therapeutics company Biofourmis has signed an agreement to buy Zurich, Switzerland-based wearable biosensor company Biovotion. The deal consists of all Biovotion’s assets, including the clinical-grade Everion® device and […]